GlobeNewswire by notified

RAPS Euro Convergence 2023 highlights information transparency, MDR and IVDR transitions and more to a sold-out audience in Amsterdam

Share

Amsterdam, May 12, 2023 (GLOBE NEWSWIRE) -- RAPS Euro Convergence 2023 concluded on Friday, as a record 650-plus attendees gathered in Amsterdam for three days of learning and networking at the most comprehensive regulatory affairs conference in Europe.


Last year’s Euro Convergence, also in Amsterdam following two years of online conferences, set the record as RAPS’ largest event in Europe. This year’s conference exceeded that mark, with delegates from more than 36 countries across five continents and setting a new benchmark for RAPS European events.

“We saw last year how important it was for the profession to attend a conference in person,” said conference committee co-chair Siegfried Schmitt, vice president, technical at Parexel. “The sold-out attendance and energy this year truly reinforce the relevance and value of RAPS Euro Convergence. It's simply fantastic!”

RAPS Euro Convergence is the most comprehensive regulatory affairs conference in Europe, focusing on the latest developments in healthcare products in Europe and beyond—medical devices, pharmaceuticals and biologics, diagnostics, and digital health. Here are some highlights from this year’s record-setting event.

An opening plenary session dedicated to transparency in European medical safety information

Wednesday’s opening plenary session marked the official start of this year’s conference with a panel discussion during which the panelists agreed that safety information related to medical products in Europe should be accessible and presented in a way that it can be understood by the public.

They argued that information in the EUDAMED database for medical devices and the EU Clinical Trials Information System (CTIS) needs to be presented in such a way that patients have enough understanding to advocate for their own care. 

“Patient safety and access to data go hand in hand,” said Jet Schouten, an investigative journalist with the Dutch newspaper NRC.

Educational sessions with leading regulatory experts, health authorities and notified bodies

Euro Convergence 2023 featured more than 40 educational sessions with leading regulatory experts from around the world. Among the presenters were more than 30 representing health authorities or notified bodies from a diverse cross-section of organisations throughout Europe. Educational sessions covered a range of topics including MDR and IVDR transition and implementation, the EU CTR, interactions with health authorities and notified bodies, artificial intelligence and more.

Topic-specific tracks in pharmaceuticals, medical devices, IVDR and regulatory business enabled delegates to get in-depth learning. A “Conversations that Matter: Interactions with Health Authorities” session gave delegates an opportunity to ask direct questions to health authority and notified body representatives in an interactive discussion format.

The chance to reconnect with global regulatory colleagues

At RAPS’ largest-ever event in Europe, professionals had the opportunity to hear about vital regulatory updates and explore dynamic collaboration opportunities and essential professional development. In addition, the sold-out tabletop exhibits at RAPS Euro Convergence allowed delegates to meet with new business partners and discuss the latest innovations from across the industry.

“At the end of the day, nothing beats an event like this,” said conference committee co-chair Alex Laan, head of IVD notified body at BSI Group. “Delegates learn so much from each other and have so many valuable experiences in between and after the presentations, which is something you can really only do if you engage one another face-to-face.”

Chapter and local networking group (LNG) meet and greets enabled delegates to reconnect with old colleagues and build new connections for future collaboration. Nine local RAPS communities came together for in-person meetups, including RAPS’ recently-launched local networking groups in Spain and Portugal.

A robust agenda that went much further than educational sessions

The conference programme also included preconference workshops, poster presentations, sponsored sessions and networking events, including a networking dinner at the historic Kanarie Club. Delegates voted “Developing Guidelines for Medical 3D Printing in Various Scenarios: A Challenging Task?” by Nivedha Subramanian as the best poster.

“It is fantastic to see how much RAPS Euro Convergence has grown in our second year back in-person,” said RAPS Executive Director Bill McMoil. “RAPS is focused on listening to and creatively serving the European regulatory affairs community and, as a result, I expect RAPS Euro Convergence to continue its phenomenal growth in the years to come.”

After two years in Amsterdam, RAPS Euro Convergence is expanding to a larger venue and heading to the Berlin Congress Center on 6-8 May in 2024. Sign up here to stay informed.

About RAPS

The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of professionals involved with regulatory and quality for healthcare products, including medical devices, pharmaceuticals and biologics, diagnostics, and digital health. Founded in 1976 as a neutral, nonprofit organization, RAPS supports and elevates the regulatory profession with education and training, professional standards, publications, research, networking, career development, and other valuable resources. RAPS is home to the Regulatory Affairs Certification (RAC), the only post-academic professional credential to recognize regulatory excellence. The society is headquartered in suburban Washington, D.C., with chapters and affiliates worldwide. www.raps.org

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Summary Notice of Pendency and Proposed Settlement of Shareholder Derivative Actions3.5.2024 22:39:16 CEST | Press release

CUPERTINO, Calif., May 03, 2024 (GLOBE NEWSWIRE) -- Apple Inc. has released the following notice: A Federal Court authorized this Notice. This is not a solicitation from a lawyer. TO: ALL PERSONS OR ENTITIES WHO OR WHICH HELD SHARES OF APPLE INC. (“APPLE” OR THE “COMPANY”) COMMON STOCK AS OF THE CLOSE OF TRADING ON APRIL 29, 2024. THIS NOTICE RELATES TO THE PENDENCY AND PROPOSED SETTLEMENT OF SHAREHOLDER DERIVATIVE LITIGATION. PLEASE READ THIS NOTICE CAREFULLY AND IN ITS ENTIRETY. IF YOU ARE A CURRENT APPLE SHAREHOLDER, THIS NOTICE CONTAINS IMPORTANT INFORMATION ABOUT YOUR RIGHTS. THIS ACTION IS NOT A “CLASS ACTION.” THUS, THERE IS NO COMMON FUND UPON WHICH YOU CAN MAKE A CLAIM FOR MONETARY PAYMENT. IF YOU DO NOT OBJECT TO THE TERMS OF THE PROPOSED SETTLEMENT OR THE AMOUNT OF ATTORNEYS’ FEES AND EXPENSES DESCRIBED IN THIS NOTICE, YOU ARE NOT OBLIGATED TO TAKE ANY ACTION. The purpose of this Notice is to inform you of: (i) the pendency of the shareholder derivative action brought on beh

CNH announces voting results of 2024 Annual General Meeting and publishes 2023 Sustainability Report3.5.2024 22:30:00 CEST | Press release

Basildon, May 3, 2024 CNH Industrial N.V. (NYSE: CNHI) today held its annual general meeting of shareholders. Shareholders re-appointed the Company’s director nominees, including Suzanne Heywood and Scott W. Wine as executive directors1, and Elizabeth Bastoni, Howard W. Buffett, Richard J. Kramer, Karen Linehan, Alessandro Nasi, Vagn Sørensen and Åsa Tamsons as non-executive directors. Shareholders also approved a dividend of $0.47 per common share (equivalent to a total distribution of approximately $585 million), and the AGM approved the Company’s Remuneration Policy. In other voting, shareholders appointed Deloitte Accountants B.V. as the independent auditor for the 2025 financial year and approved the Company’s 2023 financial statements prepared under IFRS. Details of all matters approved today by the AGM are available on the Company's website (www.cnh.com). *** The dividend is payable on May 29, 2024 to shareholders of record on May 13, 2024. Shareholders holding CNH common shares

Nokia Corporation: Repurchase of own shares on 03.05.20243.5.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 03 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 03.05.2024 Espoo, Finland – On 03 May 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL379,8083.44CEUX--BATE--AQEU--TQEX--Total379,8083.44 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of tra

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons3.5.2024 19:48:16 CEST | Press release

Bagsværd, Denmark, 3 May 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company’s board members, executives and their associated persons have reported the transactions to Novo Nordisk and have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated persons. Please find below a statement of such trading in shares issued by Novo Nordisk. Details of the person discharging managerial responsibilities/person closely associated a)Name of the Board member/Executive/Associated PersonMaziar Mike Doustdar2 Reason for the notificationa)Position/statusExecutive Vice Presidentb)Initial notification/AmendmentInitial notification3 Details of the issuera)NameNovo Nordisk A/Sb)LEI549300DAQ1CVT6CXN342

Subsea 7 S.A. notification of major holding3.5.2024 18:32:01 CEST | Press release

Luxembourg –3 May 2024 – Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced that, on 3 May 2024, Barclays Capital Securities Limited1 informed the Company that it had breached thresholds provided for by Luxembourg’s Transparency Law of 11 January 2008 on transparency requirements for issuers of securities as amended (the “Transparency Law”) as follows: On 30 April 2024 the total number of voting rights in the Company according to Article 8 and 9 of the Transparency Law attached to shares was 1,044,272 On 30 April 2024 the total number of voting rights in the Company attached to financial instruments with similar economic effect according to Article 12 (1) (a) of the Transparency Law (right to recall) was 13,906,019On 30 April 2024 the total number of voting rights in the Company attached to financial instruments with similar economic effect according to Article 12 (1) (b) of the Transparency Law (swaps) was 499,740 When combined, the above positions equate to 5.07% of voting r

HiddenA line styled icon from Orion Icon Library.Eye